Mission Statement
ONCONIX’
mission is to identify and commercialize a portfolio of highly sensitive
and specific, need oriented and patent-protected cancer diagnostics.
ONCONIX
is a cancer diagnostics
Development Company focused on the identification of promising diagnostic
tests that, having completed research and development, are poised for
commercialization.
ONCONIX seeks to establish a strong intellectual property
position by direct licensing or acquisition of technologies demonstrating
utility for the early detection of cancer and/or for monitoring treatment
efficacy.
ONCONIX partners with leading diagnostics products and
services companies to rapidly gain entry to the medical community and to
provide a conduit of its tests to patients.
